RAC 4.32% $1.55 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-53

  1. 19,093 Posts.
    lightbulb Created with Sketch. 5895
    Yes IMU's initial results appear to be promising.

    Cancer is not going to be cured by any one approach and we need as many promising and complementary approaches as possible to be advanced. IMU and RAC are not in competition with each other in anyway and the success of IMU benefits RAC and the success of RAC benefits IMU.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.070(4.32%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.62 $1.65 $1.54 $145.6K 91.60K

Buyers (Bids)

No. Vol. Price($)
2 5700 $1.55
 

Sellers (Offers)

Price($) Vol. No.
$1.59 296 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.